Mumbai, May 12 -- Pharma sector stocks in the Indian stock market showed strong resilience on Monday despite initial pressure due to the anticipated executive order by U.S. President Donald Trump aimed at cutting prescription drug prices in the United States.

The Nifty Pharma index opened the day at 20,949.70 but soon dropped sharply by more than 1,300 points, touching a low of 20,600. The early decline was in line with market expectations that Indian pharmaceutical companies could come under pressure due to the U.S. move.

However, as investor confidence improved following signs of mutual understanding between India and Pakistan on conflict issues, the market mood shifted.

This positive sentiment helped the Nifty Pharma index rebound m...